Search Results
299 results
Your search is now limited to «AbbVie» expert search.
Seeking Alpha 01/15/2019 11:56
Why AbbVie Believes In Life After (Humira's) Death - AbbVie Inc. (NYSE:ABBV.
More from Seeking Alpha:
Motley Fool 01/10/2019 08:15
But Gonzalez and AbbVie President Michael Severino expressed confidence that the big pharma company would continue to grow for years to come despite challenges for its top-selling drug.
More from Motley Fool: 01/09/2019 09:10
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
More from
ENDPOINTS 01/08/2019 07:29
In 2017, AbbVie forked out a mammoth $205 million in cash upfront to gain access to the company’s platform.
More from ENDPOINTS:
Pharmafile 01/08/2019 04:44
AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T.
More from Pharmafile: 01/04/2019 17:57
Abbvie Inc on Friday said it will record an estimated $4 billion in impairment charges related to the scrapping of its development program of Rova-T, an investigational cancer therapy.
More from
Market Exclusive 01/04/2019 17:10
e) The agreements regarding change in control by and between AbbVie and its named executive officers have been renewed through December31, 2020 in accordance with the agreement terms.
More from Market Exclusive:
FiercePharma 01/04/2019 01:24
Bristol-Myers Squibb’s Thursday announcement that it would nab Celgene for $74 billion brought “megamergers back to pharma,” as Credit Suisse analyst Vamil Divan put it in a note to clients. And the return has industry watchers wondering which company will be the next to follow suit.
More from FiercePharma:
24/7 Wall Street 01/03/2019 09:15
Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% on Thursday morning....
More from 24/7 Wall Street:
PR Newswire 01/03/2019 08:00
In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
More from PR Newswire:
FiercePharmaMarketing 01/01/2019 21:23
AbbVie's Humira holds on to TV ad crown in Dec. despite Pfizer's year-end Xeljanz push.
More from FiercePharmaMarketing:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications